Header Logo

Sascha Dublin

Concepts (318)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dementia
14
2021
112
5.770
Why?
Pneumonia
6
2017
51
2.630
Why?
Atrial Fibrillation
13
2016
170
2.270
Why?
Analgesics, Opioid
9
2020
246
2.100
Why?
Antidepressive Agents
9
2022
156
2.060
Why?
Metformin
5
2020
58
1.980
Why?
Electronic Health Records
6
2020
698
1.800
Why?
Female
69
2022
12780
1.770
Why?
Humans
78
2022
17822
1.710
Why?
Algorithms
6
2020
239
1.620
Why?
Aged
44
2022
6173
1.490
Why?
Aged, 80 and over
30
2021
1931
1.480
Why?
Sulfonylurea Compounds
3
2019
25
1.430
Why?
Hypertension, Pregnancy-Induced
2
2022
46
1.390
Why?
Male
48
2021
10145
1.330
Why?
Hypertension
6
2021
505
1.330
Why?
Risk Assessment
15
2021
1103
1.300
Why?
Community-Acquired Infections
6
2016
23
1.290
Why?
Alzheimer Disease
7
2018
46
1.290
Why?
Hypoglycemic Agents
4
2020
272
1.230
Why?
Databases, Factual
9
2022
315
1.220
Why?
Retrospective Studies
19
2022
2467
1.220
Why?
Pregnancy Outcome
6
2022
158
1.210
Why?
Dose-Response Relationship, Drug
6
2021
129
1.200
Why?
Angiotensin-Converting Enzyme Inhibitors
4
2021
86
1.180
Why?
Pregnancy
23
2022
1529
1.170
Why?
Diabetes, Gestational
4
2019
346
1.070
Why?
Washington
13
2019
383
1.030
Why?
United States
22
2021
4007
1.010
Why?
Brain
2
2017
47
0.960
Why?
Risk Factors
24
2020
3362
0.920
Why?
Medical Record Linkage
3
2014
38
0.920
Why?
Benzodiazepines
4
2022
29
0.890
Why?
Infant, Newborn, Diseases
2
2022
35
0.890
Why?
Chronic Pain
4
2017
127
0.840
Why?
Middle Aged
32
2021
8020
0.820
Why?
Young Adult
23
2021
2464
0.800
Why?
Labetalol
1
2022
9
0.800
Why?
Pregnancy Complications, Cardiovascular
2
2020
27
0.790
Why?
Diabetes Mellitus, Type 2
2
2019
755
0.770
Why?
Adult
31
2020
7708
0.770
Why?
Incidence
13
2021
1269
0.740
Why?
Angiotensin Receptor Antagonists
2
2021
53
0.730
Why?
Cognition Disorders
3
2016
31
0.720
Why?
Cognitive Dysfunction
1
2021
50
0.720
Why?
Cohort Studies
17
2021
2590
0.710
Why?
Mental Status and Dementia Tests
1
2020
1
0.700
Why?
Autopsy
3
2018
15
0.700
Why?
Premature Birth
1
2022
137
0.700
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2018
65
0.670
Why?
Vitamins
1
2020
64
0.670
Why?
Early Diagnosis
1
2019
38
0.660
Why?
Case-Control Studies
13
2016
1120
0.660
Why?
Pharmacoepidemiology
5
2021
18
0.640
Why?
Infant, Newborn
13
2022
858
0.640
Why?
Cognition
2
2020
83
0.630
Why?
Antiemetics
1
2018
4
0.630
Why?
Morning Sickness
1
2018
4
0.630
Why?
Decision Support Techniques
1
2019
88
0.630
Why?
Diabetes Mellitus
2
2020
487
0.620
Why?
Comorbidity
8
2021
597
0.610
Why?
Cholinergic Antagonists
2
2015
6
0.610
Why?
Labor, Induced
2
2014
6
0.580
Why?
Proportional Hazards Models
7
2020
711
0.580
Why?
Prescription Drug Misuse
1
2017
11
0.570
Why?
Decision Making
1
2018
184
0.560
Why?
Opioid-Related Disorders
2
2017
172
0.560
Why?
Drug Prescriptions
6
2020
151
0.540
Why?
Prospective Studies
14
2020
1286
0.530
Why?
Insulin
1
2017
213
0.530
Why?
Anesthesia, Local
1
2016
3
0.520
Why?
Anesthesia, General
1
2016
3
0.520
Why?
Histamine H2 Antagonists
3
2011
13
0.510
Why?
Antihypertensive Agents
4
2022
161
0.510
Why?
Adolescent
18
2021
3690
0.500
Why?
Patient Acceptance of Health Care
1
2019
391
0.500
Why?
Prevalence
11
2017
888
0.500
Why?
Prescription Drugs
1
2015
31
0.490
Why?
United States Department of Veterans Affairs
3
2020
128
0.480
Why?
Medical Records
2
2014
100
0.480
Why?
Pain
1
2015
79
0.480
Why?
Infant Welfare
1
2014
3
0.480
Why?
Maternal Welfare
1
2014
14
0.480
Why?
Depression
1
2019
506
0.470
Why?
Blood Glucose
3
2019
349
0.460
Why?
Qualitative Research
3
2021
256
0.450
Why?
Insurance Coverage
1
2014
106
0.440
Why?
Women's Health
1
2014
202
0.430
Why?
Time Factors
8
2020
1097
0.430
Why?
Logistic Models
8
2018
928
0.430
Why?
Diabetes Complications
2
2012
114
0.430
Why?
Perinatal Care
1
2013
12
0.420
Why?
Lisinopril
1
2012
5
0.410
Why?
Medical Records Systems, Computerized
1
2013
85
0.410
Why?
Natural Language Processing
1
2013
58
0.400
Why?
Validation Studies as Topic
1
2012
11
0.390
Why?
Hypnotics and Sedatives
1
2011
18
0.380
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2015
172
0.380
Why?
Age Factors
4
2019
923
0.380
Why?
Drug Interactions
5
2022
20
0.380
Why?
Stroke
6
2015
315
0.360
Why?
Drug Administration Schedule
3
2020
100
0.360
Why?
Pneumonia, Viral
1
2011
56
0.350
Why?
Wounds and Injuries
2
2021
47
0.350
Why?
Proton Pump Inhibitors
1
2010
24
0.340
Why?
Body Mass Index
3
2012
967
0.330
Why?
Pneumonia, Bacterial
1
2009
7
0.330
Why?
Risk
8
2020
518
0.330
Why?
Emergency Service, Hospital
3
2022
368
0.310
Why?
Delivery of Health Care, Integrated
4
2020
537
0.310
Why?
Probiotics
1
2008
4
0.300
Why?
Drug Utilization Review
3
2013
25
0.300
Why?
Gastrointestinal Tract
1
2008
6
0.300
Why?
Irritable Bowel Syndrome
1
2008
7
0.300
Why?
Influenza, Human
1
2011
265
0.300
Why?
Severity of Illness Index
2
2021
455
0.300
Why?
Focus Groups
2
2018
147
0.290
Why?
Risk Reduction Behavior
3
2017
108
0.290
Why?
Immunocompetence
3
2012
10
0.280
Why?
Population Surveillance
7
2016
264
0.280
Why?
Odds Ratio
4
2011
673
0.280
Why?
Infant
4
2022
1198
0.280
Why?
Prenatal Exposure Delayed Effects
3
2015
167
0.270
Why?
Body Size
1
2006
31
0.270
Why?
Predictive Value of Tests
5
2013
354
0.260
Why?
Geriatric Assessment
2
2016
40
0.260
Why?
Birth Certificates
4
2013
23
0.260
Why?
Prognosis
2
2019
609
0.260
Why?
Quality of Life
2
2021
511
0.260
Why?
Prehypertension
2
2016
22
0.250
Why?
Blood Pressure
3
2016
303
0.250
Why?
International Classification of Diseases
4
2013
85
0.240
Why?
Glycated Hemoglobin A
2
2020
216
0.240
Why?
Obesity
2
2012
842
0.240
Why?
Drug Utilization
3
2015
128
0.230
Why?
Surveys and Questionnaires
2
2019
1323
0.220
Why?
Abnormalities, Drug-Induced
2
2015
15
0.220
Why?
Treatment Outcome
3
2020
1265
0.210
Why?
Hospitalization
2
2021
810
0.210
Why?
Practice Patterns, Physicians'
2
2016
332
0.210
Why?
Anticonvulsants
2
2013
9
0.210
Why?
Tramadol
1
2022
1
0.210
Why?
Radiography
2
2013
39
0.210
Why?
Accidental Falls
2
2020
42
0.200
Why?
Adverse Drug Reaction Reporting Systems
2
2013
93
0.200
Why?
Methyldopa
1
2022
6
0.200
Why?
Nifedipine
1
2022
7
0.200
Why?
Muscles
1
2022
2
0.200
Why?
Carcinoma
1
2002
22
0.190
Why?
Psychotropic Drugs
1
2002
36
0.190
Why?
Brain Ischemia
2
2013
37
0.190
Why?
Glucose Tolerance Test
2
2019
111
0.190
Why?
Myocardial Infarction
3
2015
238
0.190
Why?
Follow-Up Studies
5
2016
1219
0.190
Why?
Down-Regulation
1
2021
13
0.190
Why?
Ovarian Neoplasms
1
2002
50
0.190
Why?
Bayes Theorem
4
2022
72
0.190
Why?
Drug Monitoring
1
2021
21
0.180
Why?
Continental Population Groups
2
2013
302
0.180
Why?
Drug Evaluation, Preclinical
1
2020
4
0.180
Why?
Caregivers
1
2021
129
0.170
Why?
Social Behavior
1
2020
23
0.170
Why?
Central Nervous System Agents
1
2020
4
0.170
Why?
Pilot Projects
2
2018
219
0.170
Why?
Veterans Health
1
2020
21
0.170
Why?
Health Resources
1
2020
38
0.170
Why?
Independent Living
1
2020
23
0.170
Why?
Cross-Sectional Studies
3
2015
1335
0.170
Why?
Multivariate Analysis
2
2012
569
0.170
Why?
Cerebrovascular Disorders
1
2019
34
0.160
Why?
Datasets as Topic
1
2019
20
0.160
Why?
Hospitals, Veterans
1
2019
34
0.160
Why?
Biomarkers
1
2020
310
0.160
Why?
Ondansetron
1
2018
3
0.160
Why?
Pregnancy Trimester, First
2
2015
40
0.160
Why?
Socioeconomic Factors
3
2020
630
0.150
Why?
Cerebral Cortex
1
2018
2
0.150
Why?
tau Proteins
1
2018
3
0.150
Why?
Amyloid beta-Peptides
1
2018
4
0.150
Why?
Peptide Fragments
1
2018
27
0.150
Why?
Analgesics
1
2018
27
0.150
Why?
Veterans
1
2019
143
0.150
Why?
Sex Factors
1
2019
644
0.140
Why?
European Continental Ancestry Group
1
2019
529
0.140
Why?
Practice Guidelines as Topic
2
2017
321
0.140
Why?
Adrenergic beta-Antagonists
3
2015
43
0.140
Why?
Accidents, Traffic
1
2016
15
0.140
Why?
Medication Adherence
1
2019
246
0.140
Why?
Pregnancy Complications
3
2013
201
0.130
Why?
Gestational Age
2
2016
112
0.130
Why?
African Americans
1
2019
472
0.130
Why?
Confidence Intervals
2
2010
237
0.130
Why?
Anti-Anxiety Agents
1
2016
4
0.130
Why?
Infant, Small for Gestational Age
1
2016
57
0.130
Why?
Patient Participation
1
2017
134
0.130
Why?
Disability Evaluation
1
2016
46
0.130
Why?
Trimethoprim
1
2015
4
0.130
Why?
Osteoporotic Fractures
1
2016
41
0.130
Why?
Sulfonamides
1
2015
15
0.130
Why?
Insulin, Long-Acting
1
2015
11
0.130
Why?
Social Support
1
2017
207
0.130
Why?
Eclampsia
1
2015
12
0.130
Why?
Drug Therapy, Combination
2
2015
115
0.120
Why?
Pre-Eclampsia
1
2015
44
0.120
Why?
Obstetric Labor Complications
1
2014
13
0.120
Why?
Child
4
2016
2497
0.120
Why?
Health Surveys
2
2015
261
0.120
Why?
Mass Screening
1
2020
678
0.120
Why?
Sensitivity and Specificity
2
2013
305
0.120
Why?
Residence Characteristics
1
2017
251
0.120
Why?
Infectious Disease Transmission, Vertical
1
2014
22
0.110
Why?
Elective Surgical Procedures
1
2013
8
0.110
Why?
Mothers
1
2014
106
0.110
Why?
Cesarean Section
1
2013
32
0.110
Why?
Data Mining
1
2013
17
0.110
Why?
Anti-Asthmatic Agents
1
2013
85
0.110
Why?
Valproic Acid
1
2013
3
0.110
Why?
Drugs, Generic
1
2013
4
0.110
Why?
Antiviral Agents
1
2014
95
0.110
Why?
Maternal Exposure
1
2013
62
0.110
Why?
Delivery, Obstetric
1
2013
17
0.100
Why?
Chi-Square Distribution
1
2013
154
0.100
Why?
Longitudinal Studies
4
2016
720
0.100
Why?
Prescriptions
1
2013
27
0.100
Why?
Epilepsy
1
2012
13
0.100
Why?
Quality Improvement
1
2014
194
0.100
Why?
Pharmaceutical Preparations
1
2012
11
0.100
Why?
Schizophrenia
1
2013
77
0.100
Why?
Antipsychotic Agents
1
2013
49
0.100
Why?
Neoplasms
1
2017
445
0.100
Why?
Insulin Resistance
1
2013
137
0.100
Why?
Health Services Research
1
2013
232
0.100
Why?
Pregnancy Complications, Infectious
1
2014
146
0.100
Why?
Central Nervous System Stimulants
1
2011
27
0.100
Why?
Biomedical Research
1
2012
86
0.100
Why?
Attention Deficit Disorder with Hyperactivity
1
2011
64
0.090
Why?
Delivery of Health Care
1
2014
417
0.090
Why?
Calcium Channel Blockers
1
2010
14
0.090
Why?
Insurance, Health
1
2012
183
0.090
Why?
Seizures
1
2010
29
0.090
Why?
Emergency Medical Services
2
2021
48
0.090
Why?
Anti-Ulcer Agents
1
2010
5
0.090
Why?
Asthma
1
2013
387
0.090
Why?
Probability
1
2010
79
0.090
Why?
Hypoglycemia
1
2010
49
0.090
Why?
Cardiovascular Diseases
2
2015
599
0.090
Why?
Ischemic Attack, Transient
1
2009
27
0.080
Why?
Ethnic Groups
1
2013
485
0.080
Why?
Angiotensin II Type 1 Receptor Blockers
1
2009
10
0.080
Why?
Child, Preschool
1
2013
1424
0.080
Why?
Age Distribution
2
2015
246
0.080
Why?
Leisure Activities
1
2007
31
0.070
Why?
Fibrinolytic Agents
1
2007
44
0.070
Why?
Cimetidine
1
2006
2
0.070
Why?
Randomized Controlled Trials as Topic
1
2008
329
0.070
Why?
Aspirin
1
2007
63
0.070
Why?
Warfarin
1
2007
74
0.070
Why?
Anticoagulants
1
2007
127
0.060
Why?
Research Design
1
2008
376
0.060
Why?
Guideline Adherence
1
2007
158
0.060
Why?
Electrocardiography
2
2016
42
0.060
Why?
Prostatic Neoplasms
1
2006
262
0.060
Why?
Aripiprazole
1
2022
5
0.050
Why?
Anti-Bacterial Agents
2
2015
142
0.050
Why?
Pregnancy Trimester, Third
2
2013
17
0.050
Why?
Exercise
1
2007
495
0.050
Why?
Reference Values
1
2002
93
0.050
Why?
Rats
1
2021
30
0.050
Why?
Informatics
1
2020
3
0.040
Why?
Animals
1
2021
262
0.040
Why?
Health Maintenance Organizations
2
2013
417
0.040
Why?
Patient Discharge
1
2021
154
0.040
Why?
Antineoplastic Agents
1
2017
59
0.030
Why?
Interrupted Time Series Analysis
1
2016
25
0.030
Why?
Poisson Distribution
1
2016
88
0.030
Why?
Essential Hypertension
1
2016
1
0.030
Why?
Longevity
1
2016
13
0.030
Why?
Hip Fractures
1
2016
70
0.030
Why?
Activities of Daily Living
1
2016
85
0.030
Why?
Administration, Oral
1
2015
85
0.030
Why?
Long-Term Care
1
2015
22
0.030
Why?
Survival Rate
1
2016
260
0.030
Why?
Histamine H1 Antagonists
1
2015
3
0.030
Why?
Muscarinic Antagonists
1
2015
5
0.030
Why?
Antidepressive Agents, Tricyclic
1
2015
9
0.030
Why?
Anti-Arrhythmia Agents
1
2015
12
0.030
Why?
Pain Management
1
2015
58
0.030
Why?
Sex Distribution
1
2015
190
0.030
Why?
Medicare
1
2016
205
0.030
Why?
Weight Gain
1
2016
173
0.030
Why?
Telephone
1
2015
161
0.030
Why?
Perineum
1
2013
2
0.030
Why?
Perinatal Mortality
1
2013
4
0.030
Why?
Term Birth
1
2013
8
0.030
Why?
Maternal Age
1
2014
77
0.030
Why?
Multicenter Studies as Topic
1
2014
86
0.030
Why?
Luria-Nebraska Neuropsychological Battery
1
2013
1
0.030
Why?
Intensive Care Units, Neonatal
1
2013
41
0.030
Why?
Pregnancy, Multiple
1
2013
4
0.030
Why?
Infertility, Female
1
2013
12
0.030
Why?
Pregnancy Trimester, Second
1
2013
25
0.030
Why?
Polycystic Ovary Syndrome
1
2013
19
0.030
Why?
Feasibility Studies
1
2013
114
0.030
Why?
Product Surveillance, Postmarketing
1
2013
95
0.020
Why?
Cooperative Behavior
1
2012
92
0.020
Why?
Fractures, Bone
1
2013
95
0.020
Why?
Health Care Surveys
1
2013
230
0.020
Why?
Recurrence
1
2012
189
0.020
Why?
Death, Sudden, Cardiac
1
2011
35
0.020
Why?
Data Collection
1
2012
257
0.020
Why?
Drug-Related Side Effects and Adverse Reactions
1
2012
107
0.020
Why?
Program Evaluation
1
2012
223
0.020
Why?
Prenatal Care
1
2013
130
0.020
Why?
Insurance, Pharmaceutical Services
1
2010
25
0.020
Why?
Chronic Disease
1
2012
428
0.020
Why?
Primary Health Care
1
2015
770
0.020
Why?
California
1
2013
2328
0.020
Why?
Insurance Claim Review
1
2007
61
0.020
Why?
Concepts (318)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2025 Kaiser Permanente